Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2025-12-24 @ 4:31 PM
NCT ID:
NCT02071966
Eligibility Criteria:
Inclusion Criteria:
* NSTE-ACS
* Male, 50-80 years old
* Female, postmenopausal age
Exclusion Criteria:
* Female, premenopausal age
* autoimmune disease
* infectious disease
* neoplasms
* diabetes
* chronic renal failure
* moderate or severe liver insufficiency
* GRACE risk score\>140
* ACS or cerebrovascular accidents in previous three months
* in-stent restenosis
* surgery or trauma in previous three months
* active bleeding
* fibrinolytic therapy within 24 hours before randomization
* need for oral anticoagulation therapy
* an increased risk of bradycardia
* drugs study hypersensitivity (including aspirin)
* co-administration of ticagrelor or clopidogrel with strong CYP3A4 inhibitors
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
80 Years
Study:
NCT02071966
Study Brief:
Protocol Section:
NCT02071966